The Calmer Co. Renounceable Offer Now Closes 26 August 2026

The Calmer Co. has pushed back the closing date of its $3.5 million renounceable entitlement offer to give shareholders more time to participate, including those overseas.

  • Entitlement offer extended to 26 August 2026
  • Offer price set at A$0.001 per new share
  • Includes free attaching options exercisable at $0.002
  • Offer now open to shareholders outside Australia and New Zealand
  • Funds raised aimed at supporting growth and debt repayment
An image related to The Calmer Co International Limited
Image © middle. Logo © respective owner.

Entitlement Offer Extended Amid Shareholder Demand

The Calmer Co. International Limited (ASX:CCO) has extended the closing date of its pro-rata renounceable entitlement offer to 26 August 2026. This move follows feedback from shareholders who had yet to receive the prospectus and reflects the company’s decision to include eligible investors beyond Australia and New Zealand, such as those in the United States and Fiji.

Offer Details and Incentives

Launched on 27 July, the entitlement offer allows eligible shareholders to subscribe for one new share for every existing share held as of 7:00pm AEST on 30 July 2026, at a price of A$0.001 per new share. The company aims to raise approximately A$3.5 million before costs. To sweeten the deal, shareholders receive one free attaching option for every two new shares purchased. These options carry an exercise price of $0.002 and expire 2.5 years from issue.

Revised Timetable and Next Steps

The revised timetable sets the rights trading end date at 19 August and the closing date for acceptances at 26 August. Following the close, The Calmer Co. plans to announce the results and issue new shares and options by 2 September, with trading commencing on 3 September. The company’s directors retain discretion to extend the offer further if necessary.

Capital Raise in Context of Growth Initiatives

This capital raise comes as The Calmer Co. continues to expand its footprint with new supply agreements and manufacturing partnerships. Just days earlier, the company secured a long-term supply deal for premium noble kava from Papua New Guinea and Vanuatu, valued at around A$8.65 million annually, bolstering its raw material base beyond Fiji. Additionally, a partnership with Kaiming Agro Processing aims to scale botanical extract manufacturing in Fiji, supporting global expansion of its kava, ginger, and turmeric products.

These initiatives position The Calmer Co. to leverage its growing presence in key markets, including the United States and Australia, where it recently secured Coles supermarket ranging for its Fiji Kava FZZR product. The entitlement offer proceeds are earmarked to repay secured convertible notes, expand inventory, and fund marketing and product launches across these regions.

Bottom Line?

The extension of the entitlement offer reflects The Calmer Co.’s aim to maximise shareholder participation and capital raise success, setting the stage for upcoming growth catalysts tied to new supply and manufacturing deals.

Questions in the middle?

  • Will the extended offer period translate into strong subscription uptake?
  • How will the new capital impact the company’s debt position and growth initiatives?
  • What market response will the issuance of new shares and options prompt post-listing?